RT Journal
A1 Mitka M
T1 DIetary supplements
JF JAMA
JO JAMA
YR 2009
FD April 8
VO 301
IS 14
SP 1427
OP 1427
DO 10.1001/jama.2009.447
UL http://dx.doi.org/10.1001/jama.2009.447
AB 
The March 5 report called for additional FDA regulatory authority over dietary supplement manufacturing facilities and expanded reporting of adverse health effects of these products. The report also recommended that the FDA issue guidance to industry to clarify which supplement ingredients require safety documentation before they can be marketed and also that the agency take steps to improve consumer understanding about these products (http://energycommerce.house.gov/Press_111/20090302/gaoreport.pdf).